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ABSTRACT: Achieving fast electron transfer between a material and protein is a long-standing
challenge confronting applications in bioelectronics, bioelectrocatalysis, and optobioelectronics.
Interestingly, naturally occurring extracellular electron transfer proteins bind to and reduce metal
oxides fast enough to enable cell growth, and thus could oﬀer insight into solving this coupling
problem. While structures of several extracellular electron transfer proteins are known, an
understanding of how these proteins bind to their metal oxide substrates has remained elusive
because this abiotic−biotic interface is inaccessible to traditional structural methods. Here, we use
advanced footprinting techniques to investigate binding between the Shewanella oneidensis MR-1
extracellular electron transfer protein MtrF and one of its substrates, α-Fe2O3 nanoparticles, at the
molecular level. We ﬁnd that MtrF binds α-Fe2O3 speciﬁcally, but not tightly. Nanoparticle binding
does not induce signiﬁcant conformational changes in MtrF, but instead protects speciﬁc residues on
the face of MtrF likely to be involved in electron transfer. Surprisingly, these residues are separated in
primary sequence, but cluster into a small 3D putative binding site. This binding site is located near a
local pocket of positive charge that is complementary to the negatively charged α-Fe2O3 surface, and
mutational analysis indicates that electrostatic interactions in this 3D pocket modulate MtrF−nanoparticle binding. Strikingly,
these results show that binding of MtrF to α-Fe2O3 follows a strategy to connect proteins to materials that resembles the binding
between donor−acceptor electron transfer proteins. Thus, by developing a new methodology to probe protein−nanoparticle
binding at the molecular level, this work reveals one of nature’s strategies for achieving fast, eﬃcient electron transfer between
proteins and materials.
■ INTRODUCTION
Electron transfer between a protein and inorganic material
forms the foundation for a wide range of enzyme- and microbe-
based bioelectronic,1 bioelectrocatalytic2 and optobioelec-
tronic3 applications, including bioelectronic sensing,1,4 solar
production of fuels,5 bioremediation,6 biomining,7 water
puriﬁcation,8 and microbial9 and enzymatic10 fuel cells. The
major scientiﬁc challenge in these ﬁelds is achieving electron
transfer that is energetically eﬃcient at a rate that is
commensurate with enzyme turnover.2,3,11 The coupling
distance for direct electron transfer, which requires proper
positioning of the redox site of the protein relative to the
electrode material, varies between 10 and 30 Å.12,13 To address
this challenge, researchers have sought to orient enzymes on
the electrode surface by displaying molecules on the electrode
that mimic substrates of the enzyme,14−19 by attaching
molecules that penetrate the enzyme close to an electron
relay center on the electrode,20,21 and electrostatically directed
covalent bonding of the protein to the electrode.22 However,
these approaches can only be applied to a limited set of
enzymes and are frequently speciﬁc to an isozyme. Therefore,
there exists a recognized need for new, generalizable strategies
to enable oriented binding of proteins to materials to enable
fast and eﬃcient electron transfer.2
Interestingly, a class of naturally occurring proteins,
extracellular electron transfer proteins, have the potential to
inform a generalizable strategy for eﬃcient protein-material
electron transfer. Found primarily in metal-reducing micro-
organisms, these proteins transfer electrons derived from
intracellular oxidative reactions to iron- or manganese-
containing minerals as part of cellular respiration.23 The most
well-studied extracellular electron transfer proteins are MtrC,
MtrF, and OmcA from Shewanella oneidensis MR-1, which
reduce ﬂavins, chelated Fe(III), Fe(II)oxides, and electrodes.24
OmcA, MtrC, and MtrF, all extracellular surface-displayed
decaheme cytochromes c (cyt c), adopt a similar three-
dimensional fold composed of four domains which arrange
10 hemes in a staggered cross.25−27 MtrC and MtrF are the
terminal electron acceptors in the MtrCAB and MtrDEF porin-
cyt c complexes which shuttle electrons across the outer
membrane to the extracellular surface.28 Recent quantum
mechanical and molecular dynamics simulations of MtrF show
that each heme has a diﬀerent redox potential,29−31 indicating
that this enzyme regulates electron ﬂux through the hemes.
Under anaerobic conditions, MtrC and MtrF are most
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important for reduction of extracellular Fe(III) oxides32 and
electrodes,33 while OmcA appears to be somewhat less eﬃcient
in reducing these electron acceptors.32
A variety of biophysical measurements have sought to
establish how OmcA, MtrC, and MtrF bind to minerals to
accomplish electron transfer. These studies have established
that OmcA and MtrC form bonds with the α-Fe2O3 surface
34
and that binding of OmcA to diﬀerent surfaces induces
conformational changes.35−37 However, unlike other mineral-
binding proteins,38,39 OmcA, MtrC, and MtrF do not have
repetitive stretches of residues in primary sequence that suggest
a mineral binding site. On the basis of similarity to a hematite-
binding peptide, it has been suggested that the Fe2O3 binding
site in OmcA and MtrC is composed of a Ser/Thr-Pro-Ser/Thr
sequence near heme 10.40 However, a similar site is absent in
MtrF, and molecular dynamics simulations of a model
multiheme cyt c, Stc, with the α-Fe2O3 surface suggest a very
diﬀerent mode of binding, which is driven by hydrogen-
bonding of heme propionates and acidic amino acids to the
surface.41 Thus, there is no consensus on what regions and
interactions drive binding of these extracellular electron transfer
proteins to their mineral substrates.42
Because MtrF eﬃciently catalyzes electron transfer to
extracellular solids and its redox properties have been
calculated,29−31 we chose to use it as a prototype for studying
the structural basis behind molecular recognition of metal
oxides by extracellular electron transfer proteins. We examined
the binding of MtrF to α-Fe2O3 nanoparticles using equilibrium
binding measurements, protease footprinting, X-ray foot-
printing mass spectrometry (XFMS), and site-directed muta-
genesis. Surprisingly, we ﬁnd that MtrF binds α-Fe2O3
speciﬁcally, but not tightly, and that this binding is mediated
by complementary electrostatic interactions and induces few
conformational changes in MtrF. Thus, using XFMS to probe
solvent accessibility43,44 in combination with other biophysical
techniques shows that binding between MtrF and α-Fe2O3
resembles how electron transfer proteins recognize and bind to
each other.
■ EXPERIMENTAL SECTION
Overexpression and Puriﬁcation of MtrF and MtrF Variants.
All primers, plasmids, and strains used in this study are shown in
Tables S3 and S4 and detailed descriptions of the plasmid and strain
construction are in the Supporting Information. In brief, to generate a
version of MtrF that lacked a lipid anchor, we replaced the DNA
sequence coding for the ﬁrst 24 residues of MtrF with the coding
sequence for ﬁrst 24 residues of MtrB26 to create plasmid I5077.
Plasmids coding for additional MtrF mutants were prepared via site-
directed mutagenesis using I5077 as the template. These plasmids
were transformed into E. coli WM3064 and conjugated into
S. oneidensis MR-1 to generate strains. The strains were used for
MtrF overexpression. Overexpression and puriﬁcation of the MtrF
variants were performed as described previously25 with slight variations
(see Supporting Information).
Monitoring Binding between MtrF and Nanoparticles. We
measured size of α-Fe2O3 nanoparticles using STEM imaging (see
Supporting Information). Since the nanoparticles are irregularly
shaped, we used the average surface area reported by the manufacturer,
147.5 m2/g, for calculating the absorption constant (Kads) and Gibbs
free energy (ΔG°′). We monitored intrinsic tryptophan and tyrosine
ﬂuorescence to probe MtrF binding to α-Fe2O3 and α-Al2O3.
37,45 In
brief, 3−6 mM α-Fe2O3 or 10 mM α-Al2O3 nanoparticles (Sigma-
Aldrich, St. Louis, MO) were added to 100 nM MtrF and the resulting
ﬂuorescence from tyrosine and tryptophan residues was measured via
ﬂuorimetry (Jobin Yvon Fluoromax, HORIBA Scientiﬁc, Kyoto,
Japan). The excitation and emission wavelengths were set to 280
nm and 305−380 nm, respectively, each with 5 nm slit widths. The
changes in tryptophan ﬂuorescence (360 nm) upon nanoparticle
addition were identical to those in tyrosine ﬂuorescence (310 nm)
(data not shown). The FQ data was used for determining Kads and
ΔG°′ (see Supporting Information).
We also performed sedimentation assays to monitor MtrF binding
to α-Fe2O3. In brief, 5 mM α-Fe2O3 was added to 0.5 μM MtrF and
the mixture was incubated for 5 min at room temperature to permit
binding. The mixture was centrifuged at 10 k rcf for 5 min, and then
unbound MtrF in the supernatant was separated from MtrF bound to
the nanoparticles in the pellet. The UV−visible spectrum of the
supernatant was measured and the concentration of MtrF was
determined using the Soret peak absorption at 410 nm. The
sedimentation assay data was also used for determining Kads (see
Supporting Information).
Protease Footprinting Analysis. Samples composed of 2 μM
MtrF in an appropriate buﬀer with and without 5 mM α-Fe2O3
nanoparticles were digested with 0.3 μg trypsin (Promega, Madison,
WI) at pH 7 at 37 °C for 16 h, 0.3 μg chymotrypsin (Promega) at pH
7 at 37 °C for 16 h, or 0.3 μg pepsin (Sigma-Aldrich) at pH 4 at 37 °C
for 6 h. After digestion, the samples were centrifuged at 10 k rcf for 5
min to pellet the nanoparticles, and the peptides in supernatant were
subjected to LC−MS analysis. The peptides were analyzed using an
Ascentis Peptides ES-C18 reverse phase column (2.1 mm × 100 mm,
2.7-μm particle size; Sigma-Aldrich) in an 1290 LC system coupled to
6550 iFunnel Q-TOF mass spectrometer (Agilent Technologies, San
Jose, CA). Peptide mass identiﬁcation and peptide MS/MS sequencing
were carried out using Mascot (Matrix Science, Boston, MA) and
MassHunter (Agilent Technologies) software. Additional details can
be found in the Supporting Information.
XFMS Analysis. Samples composed of 1 μM MtrF with and
without 2.5 mM nanoparticles were radiolyzed using 0, 300, 500, and
800 μs of X-ray exposure at beamline 5.3.1 as previously described.44
To facilitate precise mass determination, the thioether bonds linking
heme c to cysteine residues were cleaved and the free cysteines were
carbamidomethylated after radiolysis. Additionally, to maximize the
sequence coverage, we carried out three types of protease digestion
with the exposed and carbamidomethylated MtrF samples. The
resulting digested peptides were separated and identiﬁed by LC−MS
methods as described in protease FP analysis. See the Supporting
Information for additional experimental details.
■ RESULTS AND DISCUSSION
MtrF Binds Speciﬁcally to α-Fe2O3 Nanoparticles and
Binds More Tightly at Lower pH. Native MtrF contains a
lipoprotein signal sequence and must be solubilized using
detergent during puriﬁcation. To eliminate the need for
detergent, which would complicate our experiments, we
replaced the native lipoprotein signal sequence of MtrF with
the signal sequence of MtrB26 and expressed this construct in
S. oneidensis MR-1. The MtrF protein was secreted into the
culture medium, which facilitated subsequent puriﬁcation. After
puriﬁcation, we conﬁrmed the nonlipidated MtrF was soluble in
the absence of detergent (Figure S1A), >90% pure (Figure
S1B), full-length (Figure S1B,C), redox-active (Figure S1D),
and contained 10 hemes (Figure S1F).
To examine the interactions of MtrF with Fe(III)oxides, we
probed the binding of MtrF to 27 nm-diameter α-Fe2O3
nanoparticles (Figure S2A,B) using ﬂuorescence quenching
(FQ). Using nanoparticles of α-Fe2O3 aﬀorded enough surface
area to get good signal-to-noise in our FQ measurements. We
observed that the ﬂuorescence of MtrF was quenched relative
to the initial ﬂuorescence by addition of the α-Fe2O3
nanoparticles by as much as 80% (Figure 1A). To test if this
binding was speciﬁc for α-Fe2O3 rather than minerals with the
α-corundum lattice, we also probed FQ of MtrF with addition
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of α-Al2O3 nanoparticles. Fluorescence quenching was not
observed by MtrF with the addition of the α-Al2O3 nano-
particles (Figure S2C), indicating that MtrF exhibits chemical
speciﬁcity for binding to metal oxide surfaces. This chemical
speciﬁcity likely reﬂects the diﬀerence in the surface structure of
these metal oxides: the α-Fe2O3 surface contains Fe(III) singly
coordinated with oxygen atoms,46 while the terminal α-Al2O3
surface is covered by oxygen doubly coordinated to Al(III).47
Since the surface chemistry of α-Fe2O3 varies with pH, we
hypothesized the binding of MtrF for the α-Fe2O3 nano-
particles might be aﬀected by the pH. After determining that
MtrF is stable between pH 4 and pH 8 (Figure S1E), we
performed the FQ assay with MtrF in the range of pH 4−7.
The binding of MtrF to α-Fe2O3 under weak acidic conditions
was signiﬁcantly tighter than the quenching at neutral pH
(Figure 1A). The adsorption constants (Kads) calculated using
the FQ data show a 2-fold increase in the binding constant
(Kads at pH 4, 104 ± 3 × 10
−6 mm−2; Kads at pH 7, 48 ± 2 ×
10−6 mm−2) (Table 1). To conﬁrm these Kads, we used a
cosedimentation assay (Experimental Section). The binding
constants of MtrF for the nanoparticles at pH 4 and pH 7
(Figure 1B,C, Table 1) were very similar to those measured by
FQ, and again showed a 2-fold increase from pH 7 to pH 4.
Thus, these data show that MtrF binds speciﬁcally to α-Fe2O3
nanoparticles and with a binding aﬃnity that is ∼2-fold greater
under weak acidic conditions compared to neutral conditions.
To put MtrF binding to α-Fe2O3 in the context of other
extracellular electron transfer proteins and biomineralization
proteins, we also analyzed the binding data using a Langmuir
isotherm (see Supporting Information). We ﬁnd that MtrF
binds α-Fe2O3 nanoparticles at pH 7 with a standard Gibbs free
energy (ΔG°′) of −55 kJ/mol. This is comparable in energy to
the binding of OmcA to hematite, −28 kJ/mol,37 but is ∼60 kJ/
mol less favorable than the aﬃnity of biomineralization proteins
for their target minerals, e.g., binding of amelogenin for
hydroxyapatite has ΔG°′∼ −120 kJ/mol.48 These data indicate
that MtrF and OmcA bind to minerals less tightly than typical
biomineralization proteins.
Protease Footprinting Identiﬁes a Region near Hemes
6 and 7 As a Possible Binding Site for α-Fe2O3
Nanoparticles. We next sought to determine what regions
of MtrF bind most tightly to α-Fe2O3 nanoparticles. This
abiotic−biotic interface is inaccessible to traditional structural
techniques such as X-ray crystallography and NMR. Thus, we
turned to protease footprinting, which probes accessibility of
peptide bonds using proteolytic cleavage and has been used
extensively to identify the interaction regions between proteins
and their ligands.49−51 Using multiple protease digestions, we
probed solution accessibility of MtrF alone and the MtrF
bound to α-Fe2O3 nanoparticles (MtrF:α-Fe2O3) at both pH 4
and pH 7. In the free protein, 154 proteolytic sites of MtrF, or
23% of its peptide bonds, were susceptible to digestion across
these diﬀerent experiments (Figure S3A). The identiﬁed
proteolytic fragments covered 100% of the MtrF protein
sequence (Figure S3A), showing protease footprinting
eﬀectively probes accessibility of MtrF.
The overall cleavage patterns from MtrF and MtrF:α-Fe2O3
were very similar, yet, a few very speciﬁc and signiﬁcant
diﬀerences stood out (Figure S3). No new proteolytic
fragments were observed and no fragments became signiﬁcantly
more abundant upon α-Fe2O3 binding (Figure S3), strongly
suggesting that binding did not trigger major conformational
changes in MtrF. However, 10 proteolytic fragments, or ∼5% of
the total, that appeared in the MtrF sample were undetectable
in the α-Fe2O3:MtrF samples at pH 4 and pH 7 (Figure S3B).
Analysis of this pattern indicates that the protease cleavage sites
Figure 1. MtrF binds to α-Fe2O3 nanoparticles. (A) Fluorescence
intensity relative to initial ﬂuorescence intensity, F/Fo, of MtrF as a
function of the surface area of added α-Fe2O3 nanoparticles at pH 4.0
(closed triangles), pH 5.0 (open circles), pH 6.0 (open squares) and
pH 7.0 (closed diamonds). (B,C) Sedimentation assay of MtrF for the
nanoparticles at pH 4.0 (B) and pH 7.0 (C). Data shows the average
of two independent experiments and bars indicate the standard
deviations. The calculated adsorption constants (Kads) are shown in
Table 1.
Table 1. Calculated Adsorption Constants (Kads) of MtrF
data used for the calculation Kads
a (SD) × 10−6 [/mm2]
FQ assay at pH 4.0 104(3)
FQ assay at pH 5.0 70(10)
FQ assay at pH 6.0 54(2)
FQ assay at pH 7.0 48(2)
Sedimentation assay at pH 4.0 138(2)
Sedimentation assay at pH 7.0 54(7)
aThe adsorption constants (Kads) were calculated using FQ and
sedimentation data in Figure 1.
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at L460 and L515 are protected at pH 7 and sites L460, L469,
F512, A608 and D609 are protected at pH 4 (Figure S3B).
Protection of proteolytic sites upon ligand binding usually
occurs near the binding site, suggesting that MtrF speciﬁcally
binds α-Fe2O3 near these amino acids.
Mapping these six protected protease sites on the primary
(Figure S4) and tertiary (Figure 2) structure of MtrF yields
three striking observations. First, unlike binding sites in other
material-binding proteins, these sites are not clustered in
primary sequence, are not near regions of repetitive charge or
hydrophobicity, and are not associated with any secondary
structures (Figure S4). Second, there seem to be no sites of
protection on the back side of the protein, i.e., the side of the
MtrF lacking any exposed hemes (Figure 2), which is unlikely
to be involved in electron transfer. Third, the six protected
residues are clustered in a single domain (domain IV) in two
regions within 0.7 nm of a heme cofactor: bounding a region of
150 Å2 between hemes 6−7 (L460, L469, F512, L515) and 80
Å2 near heme 10 (A608, D609) (Figure 2). Since electron
transfer requires a heme to be within 1 nm of the mineral, these
observations suggest that the regions between hemes 6 and 7
and heme 10 of MtrF bind to α-Fe2O3 to enable protein-
mineral electron transfer.
XFMS Implicates an Area near Heme 6−7 as a Binding
Site for α-Fe2O3 Nanoparticles. The protease footprinting
qualitatively probes interactions that are sterically accessible to
a large enzyme and stable on the hour time scale, which is much
longer than the typical dissociation time found between
relatively weak binders like MtrF and α-Fe2O3. Therefore, to
determine the change in surface accessibility at higher
resolution for the interactions between MtrF and α-Fe2O3,
we turned to XFMS. In XFMS, a microsecond pulse of high-
ﬂux-density X-rays is used to generate reactive hydroxyl radicals
in situ, and covalently modify solvent accessible side chains.44,52
Since the rate of modiﬁcation of an amino acid can be
determined, XFMS reveals quantitative and ratiometric
information on solvent accessibility changes.53,54 We performed
XFMS on both MtrF and α-Fe2O3:MtrF samples at pH 4 and
pH 7. In the MtrF-only samples, we identiﬁed 16 peptide
fragments corresponding to 13 diﬀerent amino acids that were
modiﬁed (Tables S1, S2). These amino acids were distributed
throughout the solvent accessible protein surface (Figure 3),
consistent with known mechanisms of action for hydroxyl
radical modiﬁcation.44
The XFMS labeling eﬃciency was independent of amount of
Fe2O3 and therefore the method provided direct comparison of
residue speciﬁc solvent accessibilities between free and bound
sample. Therefore, we used the XFMS data for MtrF and
MtrF:α-Fe2O3 to calculate R, the ratio of hydroxyl reactivity
rate in MtrF:α-Fe2O3 to the reactivity rate in MtrF only (Figure
3B,C). In our study, R > 1.5 and R < 0.5 indicates a signiﬁcant
protection and increase in solvent accessibility of modiﬁable
residues upon α-Fe2O3 binding, respectively. Similar to the
protease footprinting experiments, at both pHs most of the
residues did not show any signiﬁcant change in solution
accessibility (R ∼ 1, Figure 3B,C). Likewise, no residues
showed an increase in solvent accessibility, i.e., R < 0.5,
indicating no signiﬁcant conformational changes occurred
(Figure 3B,C). However, a few residues were moderately (1.5
< R < 1.75) or strongly (R > 1.75) protected (Figure 3B,C,
Tables S1, S2). As was the case for protease footprinting, all the
protected residues are located on the heme-exposed side of
MtrF (Figure 3A). Remarkably, of all 13 modiﬁed residues, the
residue closest to the heme 6−7 region, M492, was strongly
protected at pH 7. M211, which is near the heme 6−7 region,
was also strongly protected, while the slightly more distant W81
was moderately protected (Figure 3C). The identiﬁcation of
the same heme 6−7 area as a protected region through two
complementary techniques probing at diﬀerent spatial and
temporal resolution indicates that this region is involved in
binding α-Fe2O3 at pH 7.
At pH 4, the XFMS protection pattern of MtrF by α-Fe2O3
also largely followed the protease footprinting pattern. First,
both the degree and spatial extent of protection were greater at
pH 4 compared to pH 7 (Figure 3A). Second, the three
modiﬁable residues surrounding the possible binding site
closest heme 6−7, M492, H216/L217 and M211, were all
strongly protected from modiﬁcation by nanoparticle binding at
pH 4 (Figure 3A, B and Table S2). Overall, these observations
indicate that MtrF speciﬁcally binds to α-Fe2O3 through a
region between hemes 6 and 7 at pH 4 and 7.
Electrostatic Complementarity between the Binding
Regions of MtrF and α-Fe2O3 Nanoparticles Contribute
to Binding. To understand what interactions drive binding
between this region of MtrF and α-Fe2O3, we used the crystal
structure of MtrF and parametrized hemes to calculate the
electrostatic map of MtrF at pH 7. Strikingly, the electrostatic
map of MtrF (Figure 4) reveals that the largest region of
positive charge on MtrF lies between hemes 6−7. Since the
surface of α-Fe2O3 nanoparticles is negatively charged at pH 7
(zeta potential = −20 mV55), we hypothesized that
Figure 2. Protease footprinting shows that heme 6−7 region and heme
10 region of MtrF are protected by α-Fe2O3 nanoparticles. The solvent
accessible regions of the protein and heme groups of MtrF (RCSB ID:
3PMQ) are shown as gray and light red surfaces, respectively, and are
shown from diﬀerent perspectives (front, bottom, back). Protease sites
protected at pH 4, pH 7, and both pH 4 and 7 are indicated as red,
blue and purple regions, respectively. The hemes are numbered in red
according to their position in primary sequence. The detailed peptide
maps of the protease FP are shown in Figure S3.
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complementary electrostatic interactions between the heme 6
and 7 region and the α-Fe2O3 surface mediate binding of MtrF
to α-Fe2O3 nanoparticles.
To test this hypothesis, we mutated the protected residues
from protease footprinting as single mutations and then in
combination to an uncharged alanine, negatively charged
aspartic acid, or positively charged lysine, and measured the
binding of these puriﬁed MtrF mutants to α-Fe2O3 nano-
particles using FQ. The MtrF mutants containing only a single
amino acid change at positions L460, F512, or L515 each
bound α-Fe2O3 at pH 7 with similar aﬃnity as wild-type MtrF
(Table 2), regardless of the mutation. Changing these three
amino acids simultaneously to alanine, L460A/F512A/L515A
(MtrF-3A), did not signiﬁcantly change the binding aﬃnity of
MtrF to α-Fe2O3. In contrast, the Kads of the mutated MtrF
with L460 K, F512 K, and L515 K (MtrF-3K) was signiﬁcantly
larger than the Kads of the wild-type protein at pH 7 (Table 2,
Figure 3. XFMS shows that amino acids located near heme 6−7 region and heme 10 of MtrF are protected by α-Fe2O3 nanoparticles. (A) Amino
acid residues moderately (yellow) or strongly (red) protected by binding of the nanoparticles at pH 4 (left) and 7 (right) as viewed from the front
and back perspective. The solvent accessible regions of the protein and heme groups of MtrF are shown as gray and light red surfaces, respectively.
(B, C) Ratio of the modiﬁcation rate for diﬀerent amino acids in MtrF at pH 4 (B) and pH 7 (C). Gray bars indicate a modiﬁcation rate ratio (MtrF
alone /α-Fe2O3:MtrF) less than 1.5, whereas yellow residues indicate moderately protected residues (R = 1.5 to 1.7) and red residues are strongly
protected residues (R > 1.7). The hemes are numbered in red according to their position in primary sequence.
Figure 4. MtrF has a positively charged region which can be expanded
by site-directed mutagenesis. (Left) Electrostatic map of MtrF at pH 7.
(Right) Predicted electrostatic map of MtrF-5K mutant at pH 7.
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Figure 5), showing that increasing positive charge near hemes 6
and 7 increases MtrF binding to the nanoparticles. Moreover,
mutating MtrF to include positive charge near heme 10 (L460
K/F512 K/L515 K/A608 K/D609 K, MtrF-5K) further
increases its binding to α-Fe2O3, such that its binding aﬃnity
is the same as wild-type MtrF’s aﬃnity to α-Fe2O3 at pH 4
(Table 2, Figure 5). This provides strong evidence that, at pH
7, electrostatic complementary between the positively charged
region between hemes 6 and 7 and the negatively charged α-
Fe2O3 surface modulates their binding.
New Strategies for Characterizing and Designing
Protein-Material Binding. These results present new insight
into the varying ways that mineral-binding proteins bind their
solid substrates. In general, biomineralization proteins, which
are frequently intrinsically disordered proteins,56 use primary
sequence regions to bind tightly to minerals (ΔG0′ ∼ 120 kJ/
mol48) and undergo signiﬁcant conformational changes57 upon
binding. Here we show MtrF uses complementary electrostatic
interactions arising from tertiary structure to bind less tightly to
its mineral substrate (ΔG0′ ∼ 50 kJ/mol) without undergoing
signiﬁcant conformational changes. Interestingly, these binding
attributes more closely resemble the structural and energetic
characteristics of electron transfer proteins in an electron
transfer complex, which bind weakly (∼25 kJ/mol)58 using
small intermolecular interaction surface area (>1000 Å2) with
few conformational changes.59,60 While additional studies are
needed to ﬁll out the atomic details and kinetics of MtrF-α-
Fe2O3 binding and their functional implications, it seems likely
that the observed similarities to donor−acceptor protein−
protein binding and dissimilarities to biomineralization protein
arise from very diﬀerent requirements for catalyzing electron
transfer versus mineral growth. Most critically, our results
illuminate that one strategy nature has used to yield eﬃcient
protein-material electron transfer is a relatively weak protein-
material interaction, which involves few conformational
changes and a small area of interfacial interaction.
Our results can also be used to understand better and
engineer extracellular electron transfer in decaheme cyts c. The
location of the MtrF binding site identiﬁes hemes 6 and 7 as the
likely donors for direct electron transfer to α-Fe2O3 at pH 7.
Supporting this hypothesis, Breuer et al.29,30 have shown via
simulation that heme 7 in MtrF has the highest redox potential,
making it the closest in redox potential to α-Fe2O3. Other
decaheme cyts c also use regions near heme 7 to transfer
electrons to diﬀerent small molecule substrates, e.g., UndA with
anthraquinone-2,6-disulfonate61 or Fe3OCit3,
62 MtrC with
ﬂavin mononucleotide.27 Thus, our work strengthens the idea
that the heme 7 region plays a main role in transferring
electrons to extracellular electron acceptors across diﬀerent
paralogs. This putative binding site also suggests that eﬀorts to
incorporate MtrF or other decaheme cyts c as a stand-
alone5,63,64 or microbially incorporated1,65−67 bioelectrocata-
lysts should orient heme 7 to the electrode interface and
suggests complementary electrostatic interactions are a means
to direct this attachment.
Lastly, our results oﬀer opportunities for characterization of
protein-material interfaces for bioelectrocatalysis and optobioe-
lectronic systems in their native protein environment. While
researchers have directed enzyme attachment to electrodes
using very strong covalent bonds11,22 (ΔG0′ ∼ 300−400 kJ/
mol), a more recent trend is to modify the electrode to mimic
substrate-enzyme interactions, which are weaker (ΔG0′ ∼ 25−
200 kJ/mol). In most cases, the strength of enzyme-electrode
binding, the degree of binding-induced conformational changes
in the protein, and the molecular-level protein−surface
interactions are unknown or only known by computation.68,69
Our work, in particular direct solvent accessibility measure-
ments using XFMS in combination with other biophysical
methods and mutational studies, presents a robust method-
ology for experimentally probing these key parameters in native
conditions and for validating computational results.
■ CONCLUSIONS
To summarize, we found that MtrF binds speciﬁcally, but not
tightly, to α-Fe2O3 nanoparticles. Remarkably, protease foot-
printing and XFMS indicate there are no signiﬁcant conforma-
tional changes upon binding, but rather point to a very speciﬁc,
small region in MtrF between hemes 6 and 7 as the
nanoparticle binding site. Calculations and mutagenesis show
that this binding is mediated by complementary electrostatic
charges. These energetic and structural binding characteristics
parallel binding between partner electron transfer. Thus, this
Table 2. Calculated Adsorption Constants (Kads) of MtrF
Mutants
protein
Kads
a (SD) × 10−6
[/mm2]
relative binding
strengthb
MtrF wild-type (pH 7) 52.0 (0.1) 1.00
MtrF wild-type (pH 4) 95 (4) 1.83
MtrF-L460A 53(2) 1.01
MtrF-L460D 61(4) 1.17
MtrF-L460K 59 (1) 1.13
MtrF-AA608−9 56(2) 1.09
MtrF-DD608−9 54(2) 1.03
MtrF-KK608−9 61(2) 1.18
MtrF-3A 52(6) 1.01
MtrF-3D 64 (0.4) 1.24
MtrF-3K 78(16) 1.50
MtrF-5K 98(4) 1.89
aThe adsorption constants (Kads) were calculated using FQ data in
Figure 5 and S6. bRelative binding strength is calculated as Kads of the
mutants or MtrF wild-type (pH 4) divided by Kads of the MtrF wild-
type (pH 7).
Figure 5. Mutations MtrF supports that amino acid residues protected
by α-Fe2O3 nanoparticles from protease digestions are very important
for binding of the nanoparticles. FQ assays of MtrF and its point-
mutations for α-Fe2O3 nanoparticles at pH 7 and pH 4. MtrF-3K
(open triangles), MtrF-5K (black squares) and the wild-type, MtrF at
pH 7 (closed circles) and at pH 4 (open diamonds).
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study of the interactions between MtrF and α-Fe2O3 nano-
particles establishes XFMS as a new way to characterize
protein−material interactions at the molecular level and reveals
one strategy nature has used to yield eﬃcient protein-material
electron transfer.
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